Biologically active carbazole derivatives: focus on oxazinocarbazoles and related compounds

Abstract Four series of carbazole derivatives, including N-substituted-hydroxycarbazoles, oxazinocarbazoles, isoxazolocarbazolequinones, and pyridocarbazolequinones, were studied using diverse biological test methods such as a CE-based assay for CK2 activity measurement, a cytotoxicity assay with IPC-81 cell line, determination of MIC of carbazole derivatives as antibacterial agents, a Plasmodium falciparum susceptibility assay, and an ABCG2-mediated mitoxantrone assay. Two oxazinocarbazoles Ib and Ig showed CK2 inhibition with IC50 = 8.7 and 14.0 µM, respectively. Further chemical syntheses were realized and the 7-isopropyl oxazinocarbazole derivative 2 displayed a stronger activity against CK2 (IC50 = 1.40 µM). Oxazinocarbazoles Ib, Ig, and 2 were then tested against IPC-81 leukemia cells and showed the ability to induce leukemia cell death with IC50 values between 57 and 62 μM. Further investigations were also reported on antibacterial and antiplasmodial activities. No significant inhibitory activity on ABCG2 efflux pump was detected.

[1]  Shu Liu,et al.  Coumestrol from the national cancer Institute’s natural product library is a novel inhibitor of protein kinase CK2 , 2013, BMC Pharmacology and Toxicology.

[2]  G. Zeng,et al.  A New Cytotoxic Carbazole Alkaloid and Two New Other Alkaloids from Clausena excavata , 2013, Chemistry & biodiversity.

[3]  Jin-Ying Tian,et al.  Bioactive carbazole alkaloids from Murraya koenigii (L.) Spreng. , 2013, Fitoterapia.

[4]  K. L. Le Roch,et al.  Recent advances in malaria drug discovery. , 2013, Bioorganic & medicinal chemistry letters.

[5]  E. Débiton,et al.  Synthesis and Biological Activities of 4‐Substituted Pyrrolo[2,3‐a]carbazole Pim Kinase Inhibitors. , 2013 .

[6]  J. Settleman,et al.  Noncovalent wild-type-sparing inhibitors of EGFR T790M. , 2013, Cancer discovery.

[7]  P. Shanmughavel,et al.  Synthesis of hetero annulated carbazoles: exploration of in vitro cytotoxicity and molecular docking studies , 2013 .

[8]  B. Bandgar,et al.  Synthesis, biological evaluation, and docking studies of 3-(substituted)-aryl-5-(9-methyl-3-carbazole)-1H-2-pyrazolines as potent anti-inflammatory and antioxidant agents. , 2012, Bioorganic & medicinal chemistry letters.

[9]  A. W. Schmidt,et al.  Occurrence, Biogenesis, and Synthesis of Biologically Active Carbazole Alkaloids , 2012 .

[10]  E. Débiton,et al.  Kinase inhibitory potencies and in vitro antiproliferative activities of N-10 substituted pyrrolo[2,3-a]carbazole derivatives. , 2012, Bioorganic & medicinal chemistry letters.

[11]  F. Totzke,et al.  Indeno[1,2-b]indole derivatives as a novel class of potent human protein kinase CK2 inhibitors. , 2012, Bioorganic & medicinal chemistry.

[12]  S. Døskeland,et al.  Cyclic AMP induces IPC leukemia cell apoptosis via CRE-and CDK-dependent Bim transcription , 2011, Cell Death and Disease.

[13]  C. Vairappan,et al.  Biological Activity of Carbazole Alkaloids and Essential Oil of Murraya koenigii Against Antibiotic Resistant Microbes and Cancer Cell Lines , 2011, Molecules.

[14]  S. Bates,et al.  The acridone derivative MBLI-87 sensitizes breast cancer resistance protein-expressing xenografts to irinotecan. , 2011, European journal of cancer.

[15]  C. Nguyen,et al.  Antitumor activity of pyridocarbazole and benzopyridoindole derivatives that inhibit protein kinase CK2. , 2010, Cancer research.

[16]  C. Bailly,et al.  Synthesis and biological activities of new furo[3,4-b]carbazoles: potential topoisomerase II inhibitors. , 2010, European journal of medicinal chemistry.

[17]  I. Kassab,et al.  Synthesis and antiproliferative activity of oxazinocarbazole and N,N-bis(carbazolylmethyl)amine derivatives. , 2010, European journal of medicinal chemistry.

[18]  Cheng‐He Zhou,et al.  Synthesis, antibacterial and antifungal activities of some carbazole derivatives. , 2010, Bioorganic & medicinal chemistry letters.

[19]  C. Götz,et al.  A CE‐based assay for human protein kinase CK2 activity measurement and inhibitor screening , 2010, Electrophoresis.

[20]  I. Kassab,et al.  Mannich Reaction of 5‐Hydroxy‐β‐carboline. Application to the Synthesis of Novel Oxazinopyrimidocarboline Derivatives. , 2009 .

[21]  I. Kassab,et al.  Mannich Reaction of 5-Hydroxy-b-carboline. Application to the Synthesis of Novel Oxazinopyrimidocarboline Derivatives , 2008 .

[22]  B. Fenet,et al.  Regioselectivity in the 1,3‐Dipolar Cycloaddition Reactions of Nitrile Oxides and Organic Azides with Bromocarbazole‐1,4‐diones. , 2007 .

[23]  S. Bates,et al.  Inhibition of ABCG2-mediated transport by protein kinase inhibitors with a bisindolylmaleimide or indolocarbazole structure , 2007, Molecular Cancer Therapeutics.

[24]  Joachim Jose,et al.  Synthesis and Biological Evaluation of 3-(Substituted-benzylidene)-1,3-dihydro-indolin Derivatives as Human Protein Kinase CK2 and p60c-Src Tyrosine Kinase Inhibitors , 2007 .

[25]  B. Fenet,et al.  Regioselectivity in the 1,3-Dipolar Cycloaddition Reactions of Nitrile Oxides and Organic Azides with Bromocarbazole-1,4-diones , 2007 .

[26]  S. Olgen,et al.  Synthesis and biological evaluation of 3-(substituted-benzylidene)-1,3-dihydro-indolin derivatives as human protein kinase CK2 and p60(c-Src) tyrosine kinase inhibitors. , 2007, Biological & pharmaceutical bulletin.

[27]  Clinical,et al.  Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically : Approved standard , 2006 .

[28]  Ø. Bruserud,et al.  Animal models of acute myelogenous leukaemia – development, application and future perspectives , 2005, Leukemia.

[29]  Z. Bouaziz,et al.  Synthesis and Diels—Alder Reactivity of ortho-Carbazolequinones. , 2005 .

[30]  W. Frank,et al.  Synthesis, antitumour activity and structure-activity relationships of 5H-benzo[b]carbazoles. , 2005, Bioorganic & medicinal chemistry.

[31]  O. Issinger,et al.  Crystal structure of a C-terminal deletion mutant of human protein kinase CK2 catalytic subunit. , 2003, Journal of molecular biology.

[32]  B. Fenet,et al.  Synthesis of Carbazolequinone Derivatives as Inhibitors ofToxoplasma gondii Purine Nucleoside Phosphorylase , 2002 .

[33]  Christine Farenc,et al.  Pk-fit: A Pharmacokinetic/Pharmacodynamic and Statistical Data Analysis Software , 2000, Comput. Biomed. Res..

[34]  Mary Jane Ferraro,et al.  Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically : approved standard , 2000 .

[35]  Z. Bouaziz,et al.  Regiospecific Hetero Diels‐Alder Synthesis of Pyrido(2,3‐b)‐ and Pyrido(3,2‐b)carbazole‐5,11‐diones. , 1997 .

[36]  Z. Bouaziz,et al.  Regiospecific hetero diels-alder synthesis of pyrido[2,3-b]- and pyrido[3,2-b]carbazole-5,11-diones , 1997 .

[37]  C. Teng,et al.  Carbazole alkaloids from Clausena excavata and their biological activity. , 1996, Phytochemistry.

[38]  M. Lanotte,et al.  Conditions controlling long-term proliferation of Brown Norway rat promyelocytic leukemia in vitro: primary growth stimulation by microenvironment and establishment of an autonomous Brown Norway 'leukemic stem cell line'. , 1983, Leukemia research.

[39]  J. Haynes,et al.  Quantitative assessment of antimalarial activity in vitro by a semiautomated microdilution technique , 1979, Antimicrobial Agents and Chemotherapy.